Core Viewpoint - The A-share market experienced a strong opening in July, with significant movements in various sectors, particularly in the chip industry and innovative pharmaceuticals, while some high-performing stocks faced declines [1][2]. Group 1: Market Performance - The Shanghai Composite Index rose by 0.39%, and the Shenzhen Component Index increased by 0.11%, while the ChiNext Index fell by 0.24% at the close [2]. - A total trading volume of nearly 1.5 trillion yuan was recorded in the A-share market [1]. Group 2: Chip Industry - The entire chip industry chain showed strong performance, with multiple stocks hitting the daily limit [1]. Group 3: Innovative Pharmaceuticals - Innovative pharmaceutical stocks surged in the afternoon, with Frontline Bio reaching the daily limit and companies like Kexing Pharmaceutical and Yuekang Pharmaceutical rising over 15% [5][8]. - The National Healthcare Security Administration announced measures to support the high-quality development of innovative drugs, focusing on issues in drug research, access, and payment systems [8]. Group 4: Chemical Sector - The chemical sector rebounded, with Aystar Chemical experiencing a rapid increase, hitting the daily limit within 8 minutes [10]. - Aystar Chemical has seen significant net inflows of over 100 million yuan in the past two days, indicating strong market interest [10]. - The rise in chemical stocks is attributed to the recent decline in international oil prices, which typically benefits chemical companies by lowering costs [13].